MI130004, a novel antibody-drug conjugate combining trastuzumab with a molecule of marine origin, shows outstanding in vivo activity against HER2 expressing tumors.
| Image |  |
|---|---|
| Description | scientific article published on 13 February 2018 |
| Author/s | |
| Publication date | February 13, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |